Fischer Medical Ventures Complete Financial Statements

FISCHER • Review detailed financials to uncover trends, confirm thesis & journal trades
3 Years of Data
2025 - 2023

Complete Financial Data Export

Export complete financial statements for Fischer Medical Ventures (FISCHER). Downloads include all available records across all periods. For market performance, see the FISCHER stock price today .

Profitability Ratios

Net Profit Margin 15.73% 2025 data
EBITDA Margin 21.35% 2025 data
Operating Margin 19.00% 2025 data
Return on Assets 3.06% 2025 data
Return on Equity 4.14% 2025 data

Balance Sheet Ratios

Current Ratio 20.28 2025 data
Debt to Equity 1.35 2025 data
Equity Ratio 73.96% 2025 data
Asset Turnover 0.19 2025 data

Year-over-Year Growth Analysis

Comparing Sept 2024 vs Sept 2025
Revenue Growth
+122.5%
Year-over-Year
EBITDA Growth
+1800.0%
Year-over-Year
Expense Growth
+79.5%
Year-over-Year
Assets Growth
+431.4%
Year-over-Year
Equity Growth
+317.3%
Year-over-Year
Liabilities Growth
+431.4%
Year-over-Year
Operating Cash Flow Growth
-1142.9%
Year-over-Year
Investing Cash Flow Growth
-331.0%
Year-over-Year
Financing Cash Flow Growth
+751.4%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Jun 2023 Dec 2023
Revenue 89 49 31 40 21 11 12 0 0 0
Expenses 70 47 19 39 18 10 11 0 0 1
EBITDA 19 3 12 1 3 1 1 0 0 -1
Operating Profit Margin % 19.00% 5.00% 18.00% 1.00% 12.00% -3.00% 3.00% 0.00% 0.00% -347.00%
Depreciation 1 1 1 0 0 0 1 0 0 0
Interest 1 0 1 0 0 0 0 0 0 0
Profit Before Tax 17 2 10 0 3 0 0 0 0 -1
Tax 3 1 5 0 0 0 0 0 0 0
Net Profit 14 1 5 0 3 0 0 0 0 -1
Earnings Per Share (₹) 2.15 -0.05 0.77 0.05 0.48 0.65 -0.05 0.00 0.00 0.00

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2025 2024 2023
ASSETS
Total Assets 457 86 0
Current Assets 365 70 0
Fixed Assets 24 15 0
Capital Work in Progress 1 0 0
Investments 11 1 0
Other Assets 422 70 0
LIABILITIES
Total Liabilities 457 86 0
Current Liabilities 18 1 1
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 338 81 0
Share Capital 64 54 0
Reserves & Surplus 244 27 0

Cash Flow Statement

Periods ₹ Crores
Particulars March 2025 March 2024
Operating Activities -87 -7
Investing Activities -125 -29
Financing Activities 315 37
Net Cash Flow 103 1